| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.74e-04 | 303 | 35 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2.21e-04 | 1244 | 35 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 2.60e-04 | 1271 | 35 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 3.85e-04 | 560 | 35 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 4.07e-04 | 566 | 35 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 4.21e-04 | 1356 | 35 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 7.18e-04 | 1459 | 35 | 9 | GO:0000977 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 7.29e-04 | 1160 | 35 | 8 | GO:0030674 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.63e-03 | 739 | 35 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.87e-03 | 140 | 35 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 2.46e-03 | 42 | 35 | 2 | GO:0140693 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 2.58e-03 | 1412 | 35 | 8 | GO:0000981 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.80e-03 | 562 | 35 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.26e-03 | 582 | 35 | 5 | GO:0140297 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | GATA4 SP1 STRN3 TAF5 TCF20 HOXD3 NKX2-1 HCFC1 NFIX NR2F1 CREBZF SP7 | 1.63e-06 | 1390 | 35 | 12 | GO:0045944 |
| GeneOntologyBiologicalProcess | response to zinc ion starvation | 1.00e-04 | 9 | 35 | 2 | GO:0120127 | |
| GeneOntologyBiologicalProcess | cellular response to zinc ion starvation | 1.00e-04 | 9 | 35 | 2 | GO:0034224 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | GATA4 SP1 TARDBP C14orf93 ARID1B FUS HOXD3 NKX2-1 HNRNPAB HCFC1 | 1.01e-04 | 1446 | 35 | 10 | GO:0010628 |
| GeneOntologyCellularComponent | chromatin | GATA4 SP1 TARDBP TNKS1BP1 ARID1B TAF5 HOXD3 NKX2-1 HNRNPAB HCFC1 NFIX CREBZF SP7 | 3.60e-07 | 1480 | 35 | 13 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | 4.20e-04 | 596 | 35 | 6 | GO:0005667 | |
| MousePheno | slow extinction of fear memory | 1.62e-05 | 3 | 33 | 2 | MP:0012318 | |
| MousePheno | increased neocortex size | 8.06e-05 | 6 | 33 | 2 | MP:0020067 | |
| MousePheno | abnormal cerebral cortex morphology | 1.03e-04 | 328 | 33 | 6 | MP:0000788 | |
| MousePheno | cognitive inflexibility | 1.50e-04 | 8 | 33 | 2 | MP:0014115 | |
| MousePheno | abnormal response to social novelty | 2.05e-04 | 49 | 33 | 3 | MP:0020395 | |
| MousePheno | abnormal cingulate gyrus morphology | 2.40e-04 | 10 | 33 | 2 | MP:0004167 | |
| Domain | Sp1_fam | 1.61e-04 | 10 | 36 | 2 | IPR030450 | |
| Domain | RRM_1 | 6.66e-04 | 208 | 36 | 4 | PF00076 | |
| Domain | RRM | 7.80e-04 | 217 | 36 | 4 | SM00360 | |
| Domain | RRM_dom | 9.23e-04 | 227 | 36 | 4 | IPR000504 | |
| Domain | RRM | 9.69e-04 | 230 | 36 | 4 | PS50102 | |
| Domain | - | 1.21e-03 | 244 | 36 | 4 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.48e-03 | 258 | 36 | 4 | IPR012677 | |
| Domain | - | 5.39e-03 | 57 | 36 | 2 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 5.58e-03 | 58 | 36 | 2 | IPR013088 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 7.81e-03 | 69 | 36 | 2 | IPR020636 | |
| Pathway | WP_ADIPOGENESIS | 1.23e-04 | 131 | 28 | 4 | M39505 | |
| Pathway | WP_ADIPOGENESIS_GENES | 1.46e-04 | 137 | 28 | 4 | MM15970 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 3.98e-04 | 73 | 28 | 3 | M39401 | |
| Pathway | WP_MITOCHONDRIAL_GENE_EXPRESSION | 6.37e-04 | 19 | 28 | 2 | M39544 | |
| Pathway | WP_MITOCHONDRIAL_GENE_EXPRESSION | 6.37e-04 | 19 | 28 | 2 | MM15973 | |
| Pubmed | GATA4 CSTF2 SP1 TARDBP ARID1B IRS4 FBN2 HRNR TAF5 TCF20 HCFC1 NFIX SP7 | 8.61e-10 | 1429 | 36 | 13 | 35140242 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.39e-08 | 877 | 36 | 10 | 20211142 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CSTF2 SP1 TARDBP C14orf93 FUS TAF5 TCF20 HNRNPAB HCFC1 NFIX NR2F1 | 4.63e-08 | 1294 | 36 | 11 | 30804502 |
| Pubmed | 7.52e-08 | 549 | 36 | 8 | 38280479 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 4.81e-07 | 701 | 36 | 8 | 30196744 | |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | 7.21e-07 | 1021 | 36 | 9 | 26760575 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21820092 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21452073 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 36963381 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21943958 | ||
| Pubmed | Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. | 1.04e-06 | 2 | 36 | 2 | 23104007 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 33159016 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 32142134 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21881207 | ||
| Pubmed | Sustained expression of TDP-43 and FUS in motor neurons in rodent's lifetime. | 1.04e-06 | 2 | 36 | 2 | 20616880 | |
| Pubmed | Trends in Understanding the Pathological Roles of TDP-43 and FUS Proteins. | 1.04e-06 | 2 | 36 | 2 | 33433879 | |
| Pubmed | Different recognition modes of G-quadruplex RNA between two ALS/FTLD-linked proteins TDP-43 and FUS. | 1.04e-06 | 2 | 36 | 2 | 33269497 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21487023 | ||
| Pubmed | ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. | 1.04e-06 | 2 | 36 | 2 | 20624952 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 26174443 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 23587065 | ||
| Pubmed | Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. | 1.04e-06 | 2 | 36 | 2 | 27015757 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 22563080 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 23041957 | ||
| Pubmed | TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. | 1.04e-06 | 2 | 36 | 2 | 23559573 | |
| Pubmed | K(v)1.5 potassium channel gene regulation by Sp1 transcription factor and oxidative stress. | 1.04e-06 | 2 | 36 | 2 | 17660393 | |
| Pubmed | RNA and the RNA-binding protein FUS act in concert to prevent TDP-43 spatial segregation. | 1.04e-06 | 2 | 36 | 2 | 38311174 | |
| Pubmed | Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans. | 1.04e-06 | 2 | 36 | 2 | 22363618 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 35384603 | ||
| Pubmed | From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models. | 1.04e-06 | 2 | 36 | 2 | 26514432 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 22427648 | ||
| Pubmed | TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. | 1.04e-06 | 2 | 36 | 2 | 20864052 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21541367 | ||
| Pubmed | Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models. | 1.04e-06 | 2 | 36 | 2 | 23172908 | |
| Pubmed | RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration. | 1.04e-06 | 2 | 36 | 2 | 30355151 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 19303844 | ||
| Pubmed | Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS. | 1.04e-06 | 2 | 36 | 2 | 21956718 | |
| Pubmed | TDP-43/FUS in motor neuron disease: Complexity and challenges. | 1.04e-06 | 2 | 36 | 2 | 27693252 | |
| Pubmed | Changes to the TDP-43 and FUS Interactomes Induced by DNA Damage. | 1.04e-06 | 2 | 36 | 2 | 31693373 | |
| Pubmed | Cytoplasmic functions of TDP-43 and FUS and their role in ALS. | 1.04e-06 | 2 | 36 | 2 | 31132467 | |
| Pubmed | Reversible induction of TDP-43 granules in cortical neurons after traumatic injury. | 1.04e-06 | 2 | 36 | 2 | 28941811 | |
| Pubmed | Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. | 1.04e-06 | 2 | 36 | 2 | 27849576 | |
| Pubmed | "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis. | 1.04e-06 | 2 | 36 | 2 | 32758633 | |
| Pubmed | Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. | 1.04e-06 | 2 | 36 | 2 | 23023293 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 34290285 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.96e-06 | 583 | 36 | 7 | 29844126 | |
| Pubmed | 2.31e-06 | 25 | 36 | 3 | 18324732 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.11e-06 | 220 | 36 | 5 | 35785414 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 22493728 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 26926802 | ||
| Pubmed | Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover. | 3.12e-06 | 3 | 36 | 2 | 31767634 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 25239623 | ||
| Pubmed | Potentiating Hsp104 activity via phosphomimetic mutations in the middle domain. | 3.12e-06 | 3 | 36 | 2 | 29788207 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 21403029 | ||
| Pubmed | Caudate atrophy on MRI is a characteristic feature of FTLD-FUS. | 3.12e-06 | 3 | 36 | 2 | 20236174 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 29308690 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 28984110 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 14988427 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 32187538 | ||
| Pubmed | Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. | 3.12e-06 | 3 | 36 | 2 | 26293199 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 21184844 | ||
| Pubmed | Induction of fibrillin-2 and periostin expression in Osterix-knockdown MC3T3-E1 cells. | 3.12e-06 | 3 | 36 | 2 | 27751812 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 23048034 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 23159876 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 27604643 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 15705566 | ||
| Pubmed | A novel missense mutation of CMT2P alters transcription machinery. | 3.12e-06 | 3 | 36 | 2 | 27615052 | |
| Pubmed | NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease. | 3.12e-06 | 3 | 36 | 2 | 34112844 | |
| Pubmed | Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations. | 3.12e-06 | 3 | 36 | 2 | 25792726 | |
| Pubmed | Gata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytes. | 3.12e-06 | 3 | 36 | 2 | 21029371 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 10871379 | ||
| Pubmed | Axonal transport defects are a common phenotype in Drosophila models of ALS. | 3.12e-06 | 3 | 36 | 2 | 27056981 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 28343865 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9388268 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 32422969 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 3.31e-06 | 908 | 36 | 8 | 19274049 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 4.76e-06 | 954 | 36 | 8 | 36373674 | |
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 5.74e-06 | 113 | 36 | 4 | 23403292 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 23463631 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 18391022 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 24489103 | ||
| Pubmed | Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins. | 6.24e-06 | 4 | 36 | 2 | 25062688 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 12235138 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 16624878 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 38458997 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 26298469 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 22292843 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 26605911 | ||
| Pubmed | Regulation of renin enhancer activity by nuclear factor I and Sp1/Sp3. | 6.24e-06 | 4 | 36 | 2 | 12591615 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 34988393 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 34404558 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 22941224 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 24089524 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 20720006 | ||
| Pubmed | RNA-binding proteins in neurological development and disease. | 6.24e-06 | 4 | 36 | 2 | 32865115 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 26334913 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 7.99e-06 | 1024 | 36 | 8 | 24711643 | |
| Pubmed | 8.57e-06 | 730 | 36 | 7 | 34857952 | ||
| Pubmed | 9.03e-06 | 274 | 36 | 5 | 34244482 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 27378374 | ||
| Interaction | CPSF1 interactions | 2.92e-07 | 255 | 36 | 7 | int:CPSF1 | |
| Interaction | TBL1XR1 interactions | 1.06e-06 | 192 | 36 | 6 | int:TBL1XR1 | |
| Interaction | TAF15 interactions | 6.66e-06 | 408 | 36 | 7 | int:TAF15 | |
| Interaction | WWTR1 interactions | 8.30e-06 | 422 | 36 | 7 | int:WWTR1 | |
| Interaction | POU2F1 interactions | 1.41e-05 | 175 | 36 | 5 | int:POU2F1 | |
| Interaction | MYCN interactions | SP1 TARDBP ARID1B IRS4 FUS HRNR TCF20 HNRNPAB HCFC1 KRT77 SP7 | 1.73e-05 | 1373 | 36 | 11 | int:MYCN |
| Interaction | SS18 interactions | 1.80e-05 | 88 | 36 | 4 | int:SS18 | |
| Interaction | CIC interactions | 1.96e-05 | 673 | 36 | 8 | int:CIC | |
| Interaction | SOX17 interactions | 2.43e-05 | 95 | 36 | 4 | int:SOX17 | |
| Interaction | GATA6 interactions | 3.02e-05 | 34 | 36 | 3 | int:GATA6 | |
| Interaction | SMARCD1 interactions | 3.25e-05 | 349 | 36 | 6 | int:SMARCD1 | |
| Interaction | SMARCC2 interactions | 3.46e-05 | 353 | 36 | 6 | int:SMARCC2 | |
| Interaction | SMARCD3 interactions | 3.88e-05 | 107 | 36 | 4 | int:SMARCD3 | |
| Interaction | NCOR1 interactions | 4.04e-05 | 363 | 36 | 6 | int:NCOR1 | |
| Interaction | TLE3 interactions | 4.92e-05 | 376 | 36 | 6 | int:TLE3 | |
| Interaction | HSP90AA1 interactions | 5.11e-05 | 1263 | 36 | 10 | int:HSP90AA1 | |
| Interaction | SMARCC1 interactions | 5.53e-05 | 384 | 36 | 6 | int:SMARCC1 | |
| Interaction | SMAD2 interactions | 5.61e-05 | 385 | 36 | 6 | int:SMAD2 | |
| Interaction | ARHGEF28 interactions | 5.73e-05 | 42 | 36 | 3 | int:ARHGEF28 | |
| Interaction | MECP2 interactions | CSTF2 SP1 TARDBP TNKS1BP1 ARID1B FUS HRNR TCF20 NKX2-1 HNRNPAB | 5.99e-05 | 1287 | 36 | 10 | int:MECP2 |
| Interaction | BCL7A interactions | 6.69e-05 | 123 | 36 | 4 | int:BCL7A | |
| Interaction | CUL2 interactions | 7.17e-05 | 591 | 36 | 7 | int:CUL2 | |
| Interaction | GATA4 interactions | 8.05e-05 | 411 | 36 | 6 | int:GATA4 | |
| Interaction | PAX9 interactions | 8.30e-05 | 130 | 36 | 4 | int:PAX9 | |
| Interaction | GABPA interactions | 8.30e-05 | 130 | 36 | 4 | int:GABPA | |
| Interaction | MDC1 interactions | 8.38e-05 | 414 | 36 | 6 | int:MDC1 | |
| Interaction | YPEL1 interactions | 8.63e-05 | 8 | 36 | 2 | int:YPEL1 | |
| Interaction | GLUD1 interactions | 9.01e-05 | 258 | 36 | 5 | int:GLUD1 | |
| Interaction | YAP1 interactions | 9.92e-05 | 1095 | 36 | 9 | int:YAP1 | |
| Interaction | NCOR2 interactions | 1.00e-04 | 264 | 36 | 5 | int:NCOR2 | |
| Interaction | CIBAR1 interactions | 1.02e-04 | 137 | 36 | 4 | int:CIBAR1 | |
| Interaction | PHF10 interactions | 1.08e-04 | 139 | 36 | 4 | int:PHF10 | |
| Interaction | SNRPC interactions | 1.17e-04 | 440 | 36 | 6 | int:SNRPC | |
| Interaction | ARID1A interactions | 1.24e-04 | 276 | 36 | 5 | int:ARID1A | |
| Interaction | RNF4 interactions | 1.30e-04 | 1412 | 36 | 10 | int:RNF4 | |
| Interaction | SMARCA4 interactions | 1.53e-04 | 462 | 36 | 6 | int:SMARCA4 | |
| Interaction | ARID2 interactions | 1.56e-04 | 153 | 36 | 4 | int:ARID2 | |
| Interaction | JUN interactions | 1.68e-04 | 470 | 36 | 6 | int:JUN | |
| Interaction | TAF4 interactions | 1.68e-04 | 156 | 36 | 4 | int:TAF4 | |
| Interaction | FLI1 interactions | 1.84e-04 | 62 | 36 | 3 | int:FLI1 | |
| Interaction | KDM6A interactions | 1.94e-04 | 162 | 36 | 4 | int:KDM6A | |
| Interaction | SP7 interactions | 1.94e-04 | 304 | 36 | 5 | int:SP7 | |
| Interaction | TOP1 interactions | 1.98e-04 | 696 | 36 | 7 | int:TOP1 | |
| Interaction | FBN2 interactions | 2.12e-04 | 65 | 36 | 3 | int:FBN2 | |
| Interaction | BICRA interactions | 2.32e-04 | 67 | 36 | 3 | int:BICRA | |
| Interaction | ESRRA interactions | 2.32e-04 | 67 | 36 | 3 | int:ESRRA | |
| Interaction | GLDC interactions | 2.50e-04 | 321 | 36 | 5 | int:GLDC | |
| Interaction | SQSTM1 interactions | 2.82e-04 | 1257 | 36 | 9 | int:SQSTM1 | |
| Interaction | AR interactions | 2.96e-04 | 992 | 36 | 8 | int:AR | |
| Interaction | SMARCD2 interactions | 3.09e-04 | 183 | 36 | 4 | int:SMARCD2 | |
| Interaction | SMC5 interactions | 3.12e-04 | 1000 | 36 | 8 | int:SMC5 | |
| Interaction | EP400 interactions | 3.15e-04 | 184 | 36 | 4 | int:EP400 | |
| Interaction | SRRT interactions | 3.26e-04 | 340 | 36 | 5 | int:SRRT | |
| Interaction | DPF2 interactions | 3.67e-04 | 349 | 36 | 5 | int:DPF2 | |
| Interaction | HNRNPA0 interactions | 3.67e-04 | 349 | 36 | 5 | int:HNRNPA0 | |
| Interaction | BAP1 interactions | 3.91e-04 | 1314 | 36 | 9 | int:BAP1 | |
| Interaction | IRF2BP1 interactions | 4.06e-04 | 81 | 36 | 3 | int:IRF2BP1 | |
| Interaction | SFPQ interactions | 4.42e-04 | 563 | 36 | 6 | int:SFPQ | |
| Interaction | SMARCB1 interactions | 4.45e-04 | 364 | 36 | 5 | int:SMARCB1 | |
| Interaction | SP1 interactions | 4.50e-04 | 365 | 36 | 5 | int:SP1 | |
| Interaction | FEV interactions | 4.57e-04 | 203 | 36 | 4 | int:FEV | |
| Interaction | PAX2 interactions | 4.68e-04 | 85 | 36 | 3 | int:PAX2 | |
| Interaction | SLX4 interactions | 4.80e-04 | 572 | 36 | 6 | int:SLX4 | |
| Interaction | RBBP4 interactions | 4.85e-04 | 573 | 36 | 6 | int:RBBP4 | |
| Interaction | MEF2D interactions | 5.01e-04 | 87 | 36 | 3 | int:MEF2D | |
| Interaction | NFIC interactions | 5.20e-04 | 210 | 36 | 4 | int:NFIC | |
| Interaction | POU5F1 interactions | 5.36e-04 | 584 | 36 | 6 | int:POU5F1 | |
| Interaction | SSBP1 interactions | 5.56e-04 | 588 | 36 | 6 | int:SSBP1 | |
| Interaction | SOX10 interactions | 5.89e-04 | 92 | 36 | 3 | int:SOX10 | |
| Interaction | ZNF608 interactions | 6.08e-04 | 93 | 36 | 3 | int:ZNF608 | |
| Interaction | HDAC1 interactions | 6.20e-04 | 1108 | 36 | 8 | int:HDAC1 | |
| Interaction | CPSF4 interactions | 6.28e-04 | 94 | 36 | 3 | int:CPSF4 | |
| Interaction | MSANTD2 interactions | 6.38e-04 | 21 | 36 | 2 | int:MSANTD2 | |
| Interaction | DPF1 interactions | 6.47e-04 | 95 | 36 | 3 | int:DPF1 | |
| Interaction | RARA interactions | 6.51e-04 | 223 | 36 | 4 | int:RARA | |
| Interaction | ERG interactions | 6.51e-04 | 223 | 36 | 4 | int:ERG | |
| Interaction | NCOA3 interactions | 6.62e-04 | 224 | 36 | 4 | int:NCOA3 | |
| Interaction | STUB1 interactions | 6.62e-04 | 608 | 36 | 6 | int:STUB1 | |
| Interaction | NFIX interactions | 6.96e-04 | 227 | 36 | 4 | int:NFIX | |
| Interaction | SS18L1 interactions | 7.09e-04 | 98 | 36 | 3 | int:SS18L1 | |
| Interaction | HDAC2 interactions | 7.35e-04 | 865 | 36 | 7 | int:HDAC2 | |
| Interaction | CYLD interactions | 7.50e-04 | 868 | 36 | 7 | int:CYLD | |
| Interaction | FKBP5 interactions | 7.97e-04 | 414 | 36 | 5 | int:FKBP5 | |
| Interaction | NACC1 interactions | 8.19e-04 | 103 | 36 | 3 | int:NACC1 | |
| Interaction | HMGA1 interactions | 8.41e-04 | 419 | 36 | 5 | int:HMGA1 | |
| Interaction | BACC1 interactions | 8.42e-04 | 104 | 36 | 3 | int:BACC1 | |
| Interaction | CSTF1 interactions | 8.42e-04 | 104 | 36 | 3 | int:CSTF1 | |
| Interaction | ATG16L1 interactions | 8.43e-04 | 1161 | 36 | 8 | int:ATG16L1 | |
| Interaction | PPIA interactions | 8.58e-04 | 888 | 36 | 7 | int:PPIA | |
| Interaction | SMAD1 interactions | 8.97e-04 | 243 | 36 | 4 | int:SMAD1 | |
| Interaction | DDX3X interactions | 9.46e-04 | 651 | 36 | 6 | int:DDX3X | |
| Interaction | EWSR1 interactions | 9.65e-04 | 906 | 36 | 7 | int:EWSR1 | |
| Interaction | IRF2BP2 interactions | 9.91e-04 | 110 | 36 | 3 | int:IRF2BP2 | |
| Interaction | HEXIM1 interactions | 1.01e-03 | 913 | 36 | 7 | int:HEXIM1 | |
| Interaction | MAX interactions | 1.01e-03 | 251 | 36 | 4 | int:MAX | |
| Interaction | PTBP1 interactions | 1.01e-03 | 437 | 36 | 5 | int:PTBP1 | |
| Interaction | PCF11 interactions | 1.02e-03 | 111 | 36 | 3 | int:PCF11 | |
| Interaction | PAX8 interactions | 1.02e-03 | 111 | 36 | 3 | int:PAX8 | |
| Interaction | CRX interactions | 1.06e-03 | 254 | 36 | 4 | int:CRX | |
| Interaction | TBR1 interactions | 1.07e-03 | 113 | 36 | 3 | int:TBR1 | |
| Cytoband | 12q13.13 | 1.28e-03 | 67 | 36 | 2 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q12 | 3.10e-03 | 105 | 36 | 2 | chr14q12 | |
| Cytoband | 1q21.3 | 3.83e-03 | 117 | 36 | 2 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 4.43e-03 | 423 | 36 | 3 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 8.09e-03 | 172 | 36 | 2 | chrXq22 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 5.54e-05 | 9 | 23 | 2 | 755 | |
| GeneFamily | RNA binding motif containing | 1.39e-04 | 213 | 23 | 4 | 725 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 2.72e-05 | 790 | 34 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 4.32e-05 | 843 | 34 | 8 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 4.36e-05 | 844 | 34 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | 6.06e-05 | 437 | 34 | 6 | gudmap_developingGonad_e11.5_testes_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 7.86e-05 | 52 | 34 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 1.39e-04 | 166 | 34 | 4 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 2.58e-04 | 814 | 34 | 7 | gudmap_developingGonad_e18.5_testes_1000 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined|Fibroblasts / Location, Cell class and cell subclass | 1.50e-05 | 186 | 36 | 4 | 403ac98f72a42721f84fbd7826f251a88ae534a2 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.50e-05 | 186 | 36 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.50e-05 | 186 | 36 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-05 | 193 | 36 | 4 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Ngfr-Inhibitory_Neuron.Chat-Gad1Gad2-Slc17a8.Ngfr_(Globus_Pallidus/Nucleus_Basalis_(GP/NB),_cholinergic)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.99e-05 | 82 | 36 | 3 | 1ed7d7f70f00d6e280cd59c54e710bb724c8b50b | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Ngfr-Inhibitory_Neuron.Chat-Gad1Gad2-Slc17a8.Ngfr_(Globus_Pallidus/Nucleus_Basalis_(GP/NB),_cholinergic)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.99e-05 | 82 | 36 | 3 | a5d3c5b7012d8ca7418670242d22aad3ed8c5191 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Ngfr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.99e-05 | 82 | 36 | 3 | cefd8c6f60ef27fb8823faddca1cf8bbd636f474 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.25e-04 | 147 | 36 | 3 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 2.84e-04 | 159 | 36 | 3 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-04 | 161 | 36 | 3 | 78cb72c462167021195917a06052bcdc367ad890 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-04 | 161 | 36 | 3 | 06e7becfd11d6ef1a45a9cfdfcb40b812600038e | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 3.39e-04 | 169 | 36 | 3 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_ANKRD20A11P|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-04 | 169 | 36 | 3 | 4034f307163bdeace58034f28b5f98ba4e040bca | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.45e-04 | 170 | 36 | 3 | 67619685a145fbd4a86d67f2c1c2ba3d5fe52fbe | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 170 | 36 | 3 | 4cd3b7e43a061948084c01713ae141b5c2c07d89 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 170 | 36 | 3 | 36c9f7f98612a72dc511c8da4358d67444f6bcf4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.63e-04 | 173 | 36 | 3 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.63e-04 | 173 | 36 | 3 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | c1e082538f31b5c98ac63f71dcca4a1211a14708 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | c36b4526970db9ccfbe2c70b00961fab9f13b133 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | 2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | eb87275da6f61ecb4fbc89421dfd27bead1e0f48 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 175 | 36 | 3 | 3883675a726dd0c6c3a7113d59be2a093ea2dc6f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.88e-04 | 177 | 36 | 3 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.95e-04 | 178 | 36 | 3 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 3.95e-04 | 178 | 36 | 3 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-04 | 178 | 36 | 3 | 39889db130216655a34796e7030ffeb372465500 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.95e-04 | 178 | 36 | 3 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.08e-04 | 180 | 36 | 3 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.08e-04 | 180 | 36 | 3 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.15e-04 | 181 | 36 | 3 | ed0ea67f0607073aedf153f8d1073b35e46127c3 | |
| ToppCell | BAL-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 4.15e-04 | 181 | 36 | 3 | f370161afef2ec827a7b194c06abb9ac1a507cbb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.35e-04 | 184 | 36 | 3 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 185 | 36 | 3 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | facs-Heart-RV|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 185 | 36 | 3 | 7cf2b0db059605032bfae60cf1b93c4c62608f0c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.49e-04 | 186 | 36 | 3 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.49e-04 | 186 | 36 | 3 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-04 | 188 | 36 | 3 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.70e-04 | 189 | 36 | 3 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.70e-04 | 189 | 36 | 3 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.70e-04 | 189 | 36 | 3 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-04 | 190 | 36 | 3 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-04 | 190 | 36 | 3 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-04 | 190 | 36 | 3 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.78e-04 | 190 | 36 | 3 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.85e-04 | 191 | 36 | 3 | 6f5d91a9583bbb30dfaa30dd9c7772995a9196be | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.85e-04 | 191 | 36 | 3 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | droplet-Heart|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-04 | 192 | 36 | 3 | 67a7e07a11091120edbccf739836235c422ec9c6 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.92e-04 | 192 | 36 | 3 | cb6f42dcffe650f7958543531d8f5412b2f2eb12 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-04 | 192 | 36 | 3 | 5890076929598e88fe9d59a4e4e858b446746ce9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.92e-04 | 192 | 36 | 3 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.00e-04 | 193 | 36 | 3 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.00e-04 | 193 | 36 | 3 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.08e-04 | 194 | 36 | 3 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | BL-critical-LOC-Epithelial-unknown_epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.08e-04 | 194 | 36 | 3 | 6140ff8e776429c9593607da418b2d9c4f399d41 | |
| ToppCell | 356C-Epithelial_cells|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.15e-04 | 195 | 36 | 3 | d913d0a6c4797d9a873ddea6f340c3f152da1cf3 | |
| ToppCell | (7)_Epithelial-A_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.15e-04 | 195 | 36 | 3 | c9a6c65ee18d83bf34a4713d306a6e30db1325c2 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-04 | 196 | 36 | 3 | 4715f19f844e7244fc4bc446cba7c8088c600fc3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-04 | 196 | 36 | 3 | 93a5d9b8bcff7d07596ef1f4f2b74f043835fc69 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-04 | 196 | 36 | 3 | 27a216af92100224818c91e298428bee25ab0af8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-04 | 196 | 36 | 3 | cbfe01ba8071864e19b37028236ae35789f630fe | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.23e-04 | 196 | 36 | 3 | de70cc301a8cbaedb0a5ea4a6442dcdaa477822d | |
| ToppCell | LAM-Epithelial-AT2|LAM / Condition, Lineage and Cell class | 5.23e-04 | 196 | 36 | 3 | 9165041ef3d56b4d069497fee03dd1c6e273211d | |
| ToppCell | LAM-Epithelial|LAM / Condition, Lineage and Cell class | 5.31e-04 | 197 | 36 | 3 | e5cf07061f6d9db7f12ac17209b267373fa2270b | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.31e-04 | 197 | 36 | 3 | 608328608cef82adc867a449216839622253d486 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS1|tumor_Lung / Location, Cell class and cell subclass | 5.31e-04 | 197 | 36 | 3 | 8336e6647604e4bdd1596ea554c22203d13782e9 | |
| ToppCell | AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.31e-04 | 197 | 36 | 3 | 8b5d4e1c33a57c899c51feb9a6f347232f8910a3 | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 5.31e-04 | 197 | 36 | 3 | 9a053a32ff9c3a85ef9a3382453acd619cc48546 | |
| ToppCell | AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.39e-04 | 198 | 36 | 3 | 92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.39e-04 | 198 | 36 | 3 | d9ffc6589ed510ffa60c591f2a0fe123210f1455 | |
| ToppCell | metastatic_Brain-Epithelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 5.46e-04 | 199 | 36 | 3 | 5c0cd611dbf2014e0ae6ce9fe8b619ceb4006e43 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.46e-04 | 199 | 36 | 3 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | control-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.46e-04 | 199 | 36 | 3 | 50e2da35edff1aadef939cfbd4549f73c1a07717 | |
| ToppCell | normal_Pleural_Fluid-Epithelial_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 5.46e-04 | 199 | 36 | 3 | 564ba7acd03be2d6e4d0850cb2c7237a788dc275 | |
| ToppCell | Epithelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.46e-04 | 199 | 36 | 3 | bbe69e44b7970f57628365ae771790f2b13d0cae | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.46e-04 | 199 | 36 | 3 | 8d71e1fc92ee24deedf23fbb1a85a7fba0d8d436 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.46e-04 | 199 | 36 | 3 | 49690494270981eec5b5261c59e0545dff90cc21 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.46e-04 | 199 | 36 | 3 | c007cd51577e31553395ceaed70ad447e5854546 | |
| ToppCell | metastatic_Brain-Epithelial_cells-Malignant_cells|metastatic_Brain / Location, Cell class and cell subclass | 5.46e-04 | 199 | 36 | 3 | 56df2b342c77b33299cfb407e1e05f42940f2946 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.55e-04 | 200 | 36 | 3 | c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.55e-04 | 200 | 36 | 3 | 25d3865aa2ced11a5ed40013e83b47d942fdf582 | |
| ToppCell | cellseq-Epithelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.55e-04 | 200 | 36 | 3 | e4204c4b864346f47d76b0f0faae96f04fed5082 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.55e-04 | 200 | 36 | 3 | 137f8f9d255c66336d4f8b44b2e3f3de721f2bf0 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.55e-04 | 200 | 36 | 3 | 0afd93c4fdcc118bcfa77f3b59f6ff7d9293a7a4 | |
| Computational | Neighborhood of ESPL1 | 6.36e-06 | 61 | 22 | 4 | MORF_ESPL1 | |
| Drug | lomustine; Down 200; 100uM; MCF7; HT_HG-U133A | 1.20e-05 | 191 | 36 | 5 | 7045_DN | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A | 1.23e-05 | 192 | 36 | 5 | 2722_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 1.40e-05 | 197 | 36 | 5 | 3769_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.40e-05 | 197 | 36 | 5 | 4299_UP | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.47e-05 | 199 | 36 | 5 | 2322_DN | |
| Disease | cortical surface area measurement | 1.99e-05 | 1345 | 35 | 9 | EFO_0010736 | |
| Disease | Frontotemporal Dementia With Motor Neuron Disease | 3.81e-05 | 8 | 35 | 2 | C3888102 | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 8.95e-05 | 12 | 35 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | cortical surface area measurement, neuroimaging measurement | 1.48e-04 | 227 | 35 | 4 | EFO_0004346, EFO_0010736 | |
| Disease | Amyotrophic lateral sclerosis | 1.84e-04 | 17 | 35 | 2 | cv:C0002736 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 3.11e-04 | 22 | 35 | 2 | C1843687 | |
| Disease | Amyotrophic Lateral Sclerosis With Dementia | 5.44e-04 | 29 | 35 | 2 | C0393554 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 5.82e-04 | 30 | 35 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | Amyotrophic Lateral Sclerosis, Guam Form | 6.22e-04 | 31 | 35 | 2 | C0543859 | |
| Disease | Hirschsprung Disease | 6.22e-04 | 31 | 35 | 2 | C0019569 | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 6.63e-04 | 32 | 35 | 2 | DOID:332 (is_implicated_in) | |
| Disease | hypospadias | 9.85e-04 | 39 | 35 | 2 | EFO_0004209 | |
| Disease | Diaphragmatic Hernia | 1.09e-03 | 41 | 35 | 2 | C0019284 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PISNNNSLGGAGGGA | 216 | Q8NFD5 | |
| GGSQPGGFSPGQNQV | 516 | P33240 | |
| QQQLQQDSGGGGGGG | 226 | P43699 | |
| GGGGGGTGCPQQQQA | 236 | P43699 | |
| ATHAGNQGGQQAGGG | 196 | P61019 | |
| RGGGGGAGEQQQQAG | 31 | P10589 | |
| ATSNGGTGQPEGGQQ | 1336 | P51610 | |
| HEGQNQAGVGGAGPG | 21 | Q96QS6 | |
| GSGQATGQPNGSGQG | 411 | Q14938 | |
| GQSQGQSQGPGSGDT | 141 | Q9UQF2 | |
| NQDQSGGGGSGGYGQ | 196 | P35637 | |
| GQSPGHGQRGSGSGQ | 421 | Q86YZ3 | |
| GRQGSGSGQSPGHGQ | 1116 | Q86YZ3 | |
| GRQGSGSGQSPGHGQ | 1586 | Q86YZ3 | |
| GRQGSGSGQSPGHGQ | 2056 | Q86YZ3 | |
| GRQGSGSGQSPGHGQ | 2526 | Q86YZ3 | |
| GNSQGGGGGSQPPGL | 96 | P31249 | |
| GGGGSQPPGLNSEQQ | 101 | P31249 | |
| QSPGQCGDNTGAGSG | 486 | Q68CR7 | |
| SGGAASGAGPGTQQG | 71 | P43694 | |
| GQAGGGGPAGQQLPQ | 51 | Q92896 | |
| LAEQQPGGGGGGQNG | 376 | P22460 | |
| PGGGGGGQNGQQAMS | 381 | P22460 | |
| FGSQGGLGGQGQGNP | 151 | Q6E0U4 | |
| GLGGQGQGNPGGLGT | 156 | Q6E0U4 | |
| GGNGGPPNFGTNTQG | 196 | Q6E0U4 | |
| SETNGGNTGSQGGNP | 26 | Q9H972 | |
| GTGGNGFAPSGNGNG | 436 | P35556 | |
| GGEAGNQGRLGSQGN | 1611 | A6NMZ7 | |
| GQGQAGRQGPQSSGT | 716 | Q9P2P1 | |
| GNGRGSGGGQGSNGQ | 496 | O14654 | |
| GQGSRGGQGSNGQGS | 526 | O14654 | |
| GGQGSNGQGSGGNQC | 531 | O14654 | |
| GAGEGSGGTTNNGPN | 31 | Q15542 | |
| SGGTTNNGPNGGGGN | 36 | Q15542 | |
| NNGPNGGGGNVAASS | 41 | Q15542 | |
| QQGPGGNLGLSPGGN | 21 | Q13033 | |
| GGGGGGGGQSQSWNQ | 256 | Q99729 | |
| NSRGGGAGLGNNQGS | 291 | Q13148 | |
| GAGLGNNQGSNMGGG | 296 | Q13148 | |
| VGGNNGGNGNGGGAF | 21 | P08047 | |
| NNAGGGSPSSGSGGN | 601 | Q9NRH2 | |
| GGGPGDAQGQNDGNT | 831 | Q7RTX0 | |
| NWLGGGQGQGDGLQG | 166 | Q8TDD2 | |
| GQGQGDGLQGTLPTG | 171 | Q8TDD2 | |
| QQGQGAGSAPSGSGS | 526 | Q9C0C2 | |
| GGGGGGGSGNDNNQA | 191 | Q9NS37 | |
| NGEGNGQSGHSAAGP | 676 | Q9UGU0 | |
| GTGGQQRGGEGQQSS | 526 | Q6UX68 | |
| QQLGGQGAAPGAGGG | 16 | Q7Z7E8 | |
| NSQVSVNGGAGGGGS | 491 | Q7Z794 |